Check Scanners
PRODUCTS
-
The PBS-0.5 Mini single use bioreactor is compatible with 300mL– 500mL working sample volumes and the best starting point for optimizing cell therapies by leveraging the benefits of vertical-wheel mixing that can be easily scaled up for larger sample volumes.
-
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.
-
Explore our advanced Spiral and Sinuous Antennas designed for rugged airborne defense applications.
-
PHCbi brand's 18.6 cu.ft (528L) ultra-low temperature freezer offers the flexibility of operating on both 115V or 220V with the switch of a power cord. This model provides enhanced security features and operates at only 4.99kWh per day. SMART features include three lock methods: facial recognition, keypad, or optional proximity card. ENERGY STAR® Certified.
-
Our injectable plants offer pre-filled water for injection (WFI) syringes in different sizes and volumes, produced according to European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP) requirements.
WHITE PAPERS AND CASE STUDIES
-
Next-Generation Fluorescence-Based Life Science Instrument
Next-gen fluorescence imaging prototype delivers compact, multi-color LED/laser illumination, high-precision optics, robust motion control, and validated imaging performance, ensuring superior sensitivity, stability, and repeatable results.
-
How Digital Transformation In Sample Management Increases Efficiency
Explore a real-world example of how a dynamic and growing CDMO implemented a lab management system to improve efficiency and data integrity for their quality control sample management workflows.
-
AI Predictive Maintenance Prevents Batch Loss And Production Shutdown
AI-powered predictive maintenance with wireless vibration sensors prevented costly batch loss and production shutdowns in pharma manufacturing by detecting and fixing equipment issues before failures occurred.
-
Elevating Diverse Patient Voices To Inspire Clinical Trial Participation
Explore the innovative approach taken during this clinical trial partnership to address the underrepresentation of minority communities in clinical trials through digital storytelling.
-
Clear MRSA Infections At Single Low Doses
Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.
-
Using Virtual Study Coordinators For EDC Entry And Query Resolution To Speed Up Data Access And Cleaning
The piece showcases how the effective use of CRIO can significantly enhance site performance, supporting recruitment and diversity objectives for sponsors.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
Vial Fogging: Practical Considerations For Vial Selection
Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.
-
Closing The Gap In Our Understanding Of Sleep Health With DHTs
What is the current state of sleep assessments in clinical trials, regulatory expectations, and what opportunities do wearable digital health technologies present?
-
RO Membranes' Protection At SWRO Facility, Asia
Atlantium HOD UV systems provide effective RO membrane protection by combining ultraviolet water disinfection technology with hydraulic and optic principles.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool And Clean Data
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
-
Progressing A Cystic Fibrosis Treatment With A Strong Culture Match
Collaborate with an experienced CMO that combines transparency, expertise, and a shared commitment to help advance complex biologics from preclinical research to clinical success.
NEWS
-
SignWell Launches NOM-151 Compliant E-Signatures In Mexico12/9/2025
Businesses across Mexico now have a more straightforward, more affordable way to sign documents online legally. SignWell, a leading e-signature platform trusted by over 65,000 businesses globally, is now officially offering NOM-151-compliant electronic signatures, ensuring legal validity under Mexican regulations.
-
EPA Grants Arizona Primacy To Protect Underground Water Resources9/10/2025
Today, U.S. Environmental Protection Agency (EPA) announced a final rule approving the State of Arizona’s request to administer all classes of underground injection wells under the Safe Drinking Water Act (SDWA).
-
Cutting, Welding, Milling And Drilling With New High-Precision FANUC Robot6/17/2025
The robot delivers path accuracy of ±0.1 mm thanks to enhanced rigidity, advanced process supervision with FANUC’s new R-50𝑖A robot controller, and the inclusion of the company’s Accuracy and Stiffness Enhancement option.
-
Subcutaneously Administered Nanotrastuzumab Matches Performance Of Herceptin HYLECTA In Minipig Study2/12/2026
Nanoform Finland Plc, the medicine performance-enhancing company, announced the results from a preclinical study designed to compare the tolerability and pharmacokinetics of Nanotratsuzumab, a nanoformed, novel, hyaluronidase-free, non-aqueous nanoparticle suspension of trastuzumab for subcutaneous delivery versus Herceptin HYLECTA™, a co-formulated product with Halozyme’s proprietary hyaluronidase enzyme marketed by Roche/Genentech.
-
ProBioGen Enters Agreement With Polpharma Biologics To Provide High-Performance Cell Line Development Services5/7/2025
ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma's biosimilar candidate, supporting their expanding pipeline.